Targeted Multiplexed Selected Reaction Monitoring Analysis Evaluates Protein Expression Changes of Molecular Risk Factors for Major Psychiatric Disorders
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Multiplexed Selected Reaction Monitoring Analysis Evaluates Protein Expression Changes of Molecular Risk Factors for Major Psychiatric Disorders
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 18, Issue 1, Pages -
Publisher
Oxford University Press (OUP)
Online
2015-05-27
DOI
10.1093/ijnp/pyu015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene—Environment Interactions in Major Depressive Disorder
- (2017) Torsten Klengel et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review
- (2014) Latha Velayudhan et al. CURRENT PHARMACEUTICAL DESIGN
- Microglial Dysregulation in Psychiatric Disease
- (2013) Luciana Romina Frick et al. Clinical & Developmental Immunology
- A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination
- (2013) Cui Li et al. GLIA
- A Highly Sensitive Targeted Mass Spectrometric Assay for Quantification of AGR2 Protein in Human Urine and Serum
- (2013) Tujin Shi et al. JOURNAL OF PROTEOME RESEARCH
- Genetics of bipolar disorder
- (2013) Nick Craddock et al. LANCET
- Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis
- (2013) LANCET
- Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis
- (2013) T Kreisel et al. MOLECULAR PSYCHIATRY
- Automated selected reaction monitoring data analysis workflow for large-scale targeted proteomic studies
- (2013) Silvia Surinova et al. Nature Protocols
- Medical use of cannabis. Cannabidiol: A new light for schizophrenia?
- (2012) Serena Deiana Drug Testing and Analysis
- Molecular Validation of the Acute Phencyclidine Rat Model for Schizophrenia: Identification of Translational Changes in Energy Metabolism and Neurotransmission
- (2012) Agnes Ernst et al. JOURNAL OF PROTEOME RESEARCH
- Cis-acting regulation of brain-specific ANK3 gene expression by a genetic variant associated with bipolar disorder
- (2012) E H Rueckert et al. MOLECULAR PSYCHIATRY
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
- (2012) Paola Picotti et al. NATURE METHODS
- Bipolar disorder ANK3 risk variant effect on sustained attention is replicated in a large healthy population
- (2012) Alex Hatzimanolis et al. PSYCHIATRIC GENETICS
- Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress
- (2012) M Mecha et al. Cell Death & Disease
- Molecular and Genetic Evidence for Abnormalities in the Nodes of Ranvier in Schizophrenia
- (2011) Panos Roussos ARCHIVES OF GENERAL PSYCHIATRY
- Progressive Brain Change in Schizophrenia: A Prospective Longitudinal Study of First-Episode Schizophrenia
- (2011) Nancy C. Andreasen et al. BIOLOGICAL PSYCHIATRY
- The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males
- (2011) Panos Roussos et al. BIPOLAR DISORDERS
- Role of Cannabinoids in Multiple Sclerosis
- (2011) John P. Zajicek et al. CNS DRUGS
- Progress in defining the biological causes of schizophrenia
- (2011) Benjamin Pickard EXPERT REVIEWS IN MOLECULAR MEDICINE
- GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo
- (2011) Kasum Azim et al. GLIA
- Protein Significance Analysis in Selected Reaction Monitoring (SRM) Measurements
- (2011) Ching-Yun Chang et al. MOLECULAR & CELLULAR PROTEOMICS
- A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas
- (2011) Terry Farrah et al. MOLECULAR & CELLULAR PROTEOMICS
- A targeted proteomics–based pipeline for verification of biomarkers in plasma
- (2011) Jeffrey R Whiteaker et al. NATURE BIOTECHNOLOGY
- Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination
- (2011) Stephen P J Fancy et al. NATURE NEUROSCIENCE
- Genome-wide supported risk variant for bipolar disorder alters anatomical connectivity in the human brain
- (2011) Julia Linke et al. NEUROIMAGE
- The Cognitive Impact of the ANK3 Risk Variant for Bipolar Disorder: Initial Evidence of Selectivity to Signal Detection during Sustained Attention
- (2011) Gaia Ruberto et al. PLoS One
- Schizophrenia Genetics: Where Next?
- (2011) Y. Kim et al. SCHIZOPHRENIA BULLETIN
- Long acting injection versus oral risperidone in first-episode schizophrenia: Differential impact on white matter myelination trajectory
- (2011) George Bartzokis et al. SCHIZOPHRENIA RESEARCH
- Deletion of human GP1BB and SEPT5 is associated with Bernard-Soulier syndrome, platelet secretion defect, polymicrogyria, and developmental delay
- (2011) Ingrid Bartsch et al. THROMBOSIS AND HAEMOSTASIS
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats
- (2010) Marylou V. Solbrig et al. EXPERIMENTAL NEUROLOGY
- The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation
- (2010) Oscar Gomez et al. GLIA
- Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort
- (2010) Lavinia Athanasiu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Myelination in Bipolar Patients and the Effects of Mood Stabilizers on Brain Anatomy
- (2009) Paolo Brambilla et al. CURRENT PHARMACEUTICAL DESIGN
- Statistical Design of Quantitative Mass Spectrometry-Based Proteomic Experiments
- (2009) Ann L. Oberg et al. JOURNAL OF PROTEOME RESEARCH
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- High-throughput generation of selected reaction-monitoring assays for proteins and proteomes
- (2009) Paola Picotti et al. NATURE METHODS
- Glutamatergic dysfunction in schizophrenia: From basic neuroscience to clinical psychopharmacology
- (2008) Rodrigo D. Paz et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Cyclin-Dependent Kinase 5 Phosphorylation of Human Septin SEPT5 (hCDCrel-1) Modulates Exocytosis
- (2008) N. D. Amin et al. JOURNAL OF NEUROSCIENCE
- Targeted Quantitative Analysis ofStreptococcus pyogenesVirulence Factors by Multiple Reaction Monitoring
- (2008) Vinzenz Lange et al. MOLECULAR & CELLULAR PROTEOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started